| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.700 | None | 1.000 | 9 | 0 | 1997 | 2020 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.600 | None | 1.000 | 7 | 0 | 1992 | 2019 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.600 | None | 1.000 | 7 | 0 | 1998 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.600 | None | 1.000 | 7 | 0 | 2003 | 2020 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.600 | None | 0.800 | 6 | 0 | 1999 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2002 | 2019 | ||||||||
|
tryptophan hydroxylase 2 | 0.546 | 0.654 | 2.5E-07 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2005 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.600 | None | 0.600 | 6 | 0 | 1995 | 2020 | ||||||||
|
potassium two pore domain channel subfamily K member 2 | 0.626 | 0.654 | 1.9E-02 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 1997 | 2019 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.590 | None | 1.000 | 6 | 0 | 2003 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.530 | None | 1.000 | 6 | 0 | 2004 | 2018 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.620 | None | 1.000 | 5 | 0 | 2003 | 2018 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.570 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
cannabinoid receptor 2 | 0.509 | 0.846 | 6.5E-06 |
|
disease | 0.550 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 2001 | 2016 | ||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 1983 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.500 | None | 1.000 | 5 | 0 | 1997 | 2020 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.470 | None | 1.000 | 5 | 0 | 2002 | 2019 | |||||||||
|
solute carrier family 18 member A2 | 0.554 | 0.769 | 7.6E-02 |
|
disease | 0.460 | None | 1.000 | 5 | 0 | 2006 | 2019 | ||||||||
|
period circadian regulator 2 | 0.488 | 0.846 | 0.71 |
|
disease | 0.450 | None | 1.000 | 5 | 0 | 2010 | 2018 | ||||||||
|
presenilin 1 | 0.469 | 0.846 | 0.97 |
|
disease | 0.440 | None | 1.000 | 5 | 0 | 2000 | 2018 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit beta3 | 0.546 | 0.615 | 0.95 |
|
disease | 0.430 | None | 1.000 | 5 | 0 | 2001 | 2012 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 2002 | 2020 |